Ï㽶ÊÓƵ

Board of Advisors (BoA)

A. Membership:

Name Role Department/Institution Term
Joaquin Ortega Director

Anatomy & Cell Biology/McGill

04-2022/03-2027
Hojatollah Vali

Director Emeritus

Anatomy & Cell Biology/McGill

Unlimited

Audrey Moores

Associate Director

Chemistry/McGill 04-2022/03-2027
Mike Strauss (Chair) Technical Director Anatomy & Cell Biology/McGill 05-2018/04-2023
S Kelly Sears Research Manager/Staff Scientist FEMR/McGill Unlimited
Alba Guarne Member Biochemistry/McGill 04-2022/03-2027
Timothy Kennedy Member Montreal Neurological Institute/McGill 11-2020/10-2025
Shreya Krishnan Member (Trainee) Biochemistry/McGill 10-2022/09-2027
Marc McKee Member Dentistry/McGill 03-2021/02-2026
John Pascal Member Biochemistry & Molecular Medicine/UdeM 10-2019/09-2024
Natalie Reznikov Member Bioengineering/McGill 04-2022/03-2027
Alfredo Ribeiro-da-Silva Member Pharmacology/McGill 10-2022/09-2027
Natalie Zeytuni Member Anatomy & Cell Biology/McGill 04-2022/03-2027

B. Mandate:

The BoA establishes the scientific direction of the FEMR, proposes improvements to the infrastructure through CFI and other funding bodies, management (including proposing instrument and user fees), and staffing of the facility. It approves the annual budget. It also ensures the research infrastructure and resources of the FEMR are allocated to stakeholders according to their needs, scientific priorities, and financial support to the FEMR. The BoA also approves major training activities (e.g. workshops, summer school, etc.). The BoA prepares the annual report.

C. Meeting frequency:

Biannually.

D. Relationship to other committees:

Reports to the Board of Directors (BoD) on an annual basis and to the International Scientific Advisory Committee (ISAC) every three years.

Back to top